Biotechnology and health care executive Yin Ho has a unique background: She got an MD from Yale and was an emergency physician, but then decided to switch gears and went and got an MBA from Harvard. While that combination created challenges for her career, it actually set her up well for this moment we find ourselves in: As AI transforms the way we look at patient treatment options and disease research, it will take leaders like Yin who see the possibilities and the limitations, and are prepared to have hard conversations about whether we should use AI or if the human brain is still better at solving some of these issues instead.